Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

3.6K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.6K
Menopause01:28

Menopause

3.2K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.2K
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

1.4K
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
1.4K
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

9.6K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
9.6K
Infertility in Males01:23

Infertility in Males

390
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
390
Spermatogenesis01:41

Spermatogenesis

107.0K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
107.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Bidirectional Association Between MASLD and Male Hypogonadism: An Updated Meta-Analysis.

Andrology·2026
Same author

Testosterone Therapy After Radical Prostatectomy: Insights From a Systematic Review and Meta-Analysis.

Andrology·2026
Same author

A comparative evaluation of on-demand phosphodiesterase-5 inhibitor efficacy in erectile dysfunction treatment: a systematic review and network meta-analysis of double-blind, placebo-controlled, randomized trials.

The journal of sexual medicine·2026
Same author

Correction: Penile prosthesis implantation: a systematic review of intraoperative and postoperative complications.

International journal of impotence research·2026
Same author

Iron overload disorders in adults: a comprehensive review of gonadal function, reproductive, and sexual health.

Human reproduction update·2026
Same author

Emerging Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Male Sexual Hormones and Behaviors: Systematic Review and Meta-Analysis.

Andrology·2026

Related Experiment Video

Updated: Nov 12, 2025

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.6K

Sexual function in men undergoing androgen deprivation therapy.

G Corona1, S Filippi2, P Comelio2

  • 1Endocrinology Unit, Maggiore-Bellaria Hospital, Medical Department, Azienda USL Bologna, Bologna, Italy. jocorona@libero.it.

International Journal of Impotence Research
|March 22, 2021
PubMed
Summary

Androgen deprivation therapy (ADT) negatively impacts male sexual function and well-being. Patient and physician knowledge on managing ADT

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.5K
Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

46.6K

Related Experiment Videos

Last Updated: Nov 12, 2025

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.6K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.5K
Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

46.6K

Area of Science:

  • Urology
  • Oncology
  • Sexual Medicine

Background:

  • Androgen deprivation therapy (ADT) is associated with significant adverse effects on male sexual function and overall well-being.
  • There is a notable deficit in patient, couple, and physician knowledge regarding ADT side effects and their management strategies.
  • Sexual health remains a crucial component of quality of life for men undergoing ADT and their partners.

Purpose of the Study:

  • To critically review and synthesize existing evidence on the association between ADT and sexual dysfunction.
  • To discuss the most effective therapeutic options for managing ADT-induced sexual dysfunction.
  • To highlight the importance of patient education and multidisciplinary collaboration in supporting men on ADT.

Main Methods:

  • Systematic review and critical discussion of preclinical and clinical data.
  • Analysis of evidence regarding the impact of ADT on libido, erectile function, and penile contractility.
  • Evaluation of therapeutic strategies, including pharmacotherapy and non-pharmacological approaches.

Main Results:

  • ADT is linked to impaired penile contractility and reduced responsiveness to phosphodiesterase type 5 inhibitors (PDE5i).
  • ADT increases the risk of reduced libido (5-6 fold) and erectile dysfunction (ED) (3 fold), underscoring testosterone's role in sexual desire.
  • Effective management requires personalized approaches considering patient and couple needs, potentially including non-penetrative sexual activities.

Conclusions:

  • ADT significantly contributes to sexual dysfunction, necessitating proactive management strategies.
  • A comprehensive, personalized educational program involving a multidisciplinary team is crucial for optimal patient support.
  • Addressing sexual health concerns is vital for maintaining the well-being of men undergoing ADT and their partners.